Clinical Trial 21793

Cancer Type: Multiple
Study Type: Other
NCT#:

Phase: N/A
Principal Investigator: Jim, Heather

Call 813-745-6100
or 1-800-679-0775 Learn More

Overview

Study Title

Cancer-Related Cognitive Impairment: Real-Time Evaluation and Assessment of Long-Term Impact of Treatment on Young Adult Survivors (CRCI REALITY)

Summary

Objective

Aim 1: To understand YA survivors experience with long-term CRCI. Aim 2: To pilot real time assessment of long-term CRCI (with EMA) and SBCF (with EMA and actigraphy) among YA survivors.

Treatments

Therapies

Medications

Inclusion Criteria

Inclusion Criteria:

Age 18-30 years

Diagnosed with any type of non-central nervous system cancer within the last 5 years

Have self-reported cancer related cognitive impairment (CRCI)

Able to speak and read English

Exclusion Criteria

Exclusion Criteria:

Evidence of central nervous system metastases

Documented or observable psychiatric or neurological disorders that would interfere with study participation (i.e., schizophrenia, epilepsy)

Recent history (within the last 5 years) of brain injury or stroke

Participants in Aim 1 are excluded from Aim 2

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Clinical Trials Search

Advanced Search